Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine TumorsJonathan Strosberg, Eric P. Krenning, Jack L. Erion et al.|New England Journal of Medicine|2017Cited by 3.2k